1 |
Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Alzheimer Dis Assoc Disord. 1988;2:134.
|
2 |
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245-4249.
DOI
|
3 |
통계청. 2020 가구주 치매 진단 여부, 고령자(65세이상) 가구(일반가구). 국가통계포털(KOSIS) 통계표.
|
4 |
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, et al. AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011;58:818-828.
DOI
|
5 |
Santiago Bullich, Victor L. Villemagne, Ana M. Catafau, Aleksandar Jovalekic, Norman Koglin, Christopher C. Rowe and Susan De Santi. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET. J Nucl Med. 2017;58:1300-1306.
DOI
|
6 |
De Santi S, Catafau AM, Seibyl J, Bullich S. Robustness of 18F-florbetaben SUVR cutoff quantification across reference regions and standards of truth [abstract]. J Nucl Med. 2016;57:458.
|
7 |
Bullich S, Catafau AM, Seibyl J, De Santi S. Classification of positive and negative 18F-Florbetaben scans: comparison of SUVR cutoff quantification and visual assessment performance [abstract]. J Nucl Med. 2016;57:516.
|
8 |
박해정. 뇌기능 양전자방출단층촬영영상 분석 기법의 방법론적 고찰. 핵의학 분자영상. 2007;41:71-77
|
9 |
Kevin Koser. Affine Registration. Springer US. 2014:22-25
|
10 |
Evans, Alan C., et al. An MRI-based probabilistic atlas of neuroanatomy: Magnetic resonance scanning and epilepsy. Springer, Boston, MA. 1994:263-274.
|
11 |
Barthel H, Bullich S, Sabri O, Seibyl J, Villemagne V, Rowe C, et al. 18F-Florbetaben (FBB) PET SUVR quantification: which reference region [abstract]? J Nucl Med. 2015;56(suppl 3):1563.
|